Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-13-031640)

Filing Details

Accession Number:: 0001209191-13-031640
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-06-11 17:15:47
Reporting Period:: 2013-06-10

Filing Date:: 2013-06-11
Accepted Time:: 2013-06-11 17:15:47
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1333248	Cadence Pharmaceuticals Inc	CADX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1557146	Malcolm Lloyd-Smith	12481 High Bluff Dr. Ste. 200 San Diego CA 92130	Svp, Reg Affairs, Qual & Clin	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-06-10	4,000	$7.44	2,332	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 9, 2013.